Close Menu

NEW YORK (GenomeWeb) – Caribou Biosciences today announced it has granted Integrated DNA Technologies the rights to commercialize CRISPR/Cas9 reagents.

Under the terms of the non-exclusive license agreement, IDT has worldwide rights to sell CRISPR/Cas9 reagents for research use only.

Financial and other details were not disclosed 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.